[HTML][HTML] Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship
KJ Ruddy, EP Winer - Annals of oncology, 2013 - Elsevier
Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …
cancer in men are poorly understood. Design A systematic review of the English language …
[HTML][HTML] Male breast cancer
M Yalaza, A İnan, M Bozer - The journal of breast health, 2016 - ncbi.nlm.nih.gov
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …
[HTML][HTML] HER2-low breast cancer: incidence, clinicopathologic features, and survival outcomes from real-world data of a large nationwide cohort
X Baez-Navarro, MR van Bockstal, ER Andrinopoulou… - Modern Pathology, 2023 - Elsevier
Patients with breast cancer (BC) with low levels of human epidermal growth factor receptor 2
(HER2) expression (HER2-low) could benefit from novel antibody–drug conjugates …
(HER2) expression (HER2-low) could benefit from novel antibody–drug conjugates …
Male breast cancer
C Gómez-Raposo, FZ Tévar, MS Moyano… - Cancer treatment …, 2010 - Elsevier
Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …
increased over the past 25years. The rarity of this entity precludes prospective randomized …
[HTML][HTML] Molecular subtyping of male breast cancer by immunohistochemistry
R Kornegoor, AHJ Verschuur-Maes, H Buerger… - Modern Pathology, 2012 - Elsevier
Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …
females. Immunohistochemical surrogates have been used for this classification, because …
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …
ordinated multi-centre approach, we present the first large scale biomarker study to define …
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - thelancet.com
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …
in their molecular landscapes. In this systematic review, we consolidated all existing …
[HTML][HTML] Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic …
I Johansson, C Nilsson, P Berglund, M Lauss… - Breast Cancer …, 2012 - Springer
Introduction Male breast cancer (MBC) is a rare and inadequately characterized disease.
The aim of the present study was to characterize MBC tumors transcriptionally, to classify …
The aim of the present study was to characterize MBC tumors transcriptionally, to classify …
Male breast cancer is not congruent with the female disease
IS Fentiman - Critical reviews in oncology/hematology, 2016 - Elsevier
It has become customary to extrapolate from the results of treatment trials for female
breastcancer and apply them to males with the disease. In the absence of results from …
breastcancer and apply them to males with the disease. In the absence of results from …
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy
L Ottini, V Silvestri, P Rizzolo, M Falchetti… - Breast cancer research …, 2012 - Springer
Recently, the number of studies on male breast cancer (MBC) has been increasing.
However, as MBC is a rare disease there are difficulties to undertake studies to identify …
However, as MBC is a rare disease there are difficulties to undertake studies to identify …